Genetic polymorphisms and breast cancer risk: evidence from meta-analyses, pooled analyses, and genome-wide association studies Sihua PengBingjian LüMaode Lai Review 29 March 2011 Pages: 309 - 324
Clinical significance of sentinel lymph node isolated tumour cells in breast cancer Neill PataniKefah Mokbel Review 01 April 2011 Pages: 325 - 334
Management of radial sclerosing lesions of the breast diagnosed using percutaneous vacuum-assisted core needle biopsy: recommendations for excision based on seven years’ of experience at a single institution Erika ResetkovaMarcia EdelweissWei T. Yang Original Paper 15 July 2008 Pages: 335 - 343
Amplification of ESR1 may predict resistance to adjuvant tamoxifen in postmenopausal patients with hormone receptor positive breast cancer Kirsten Vang NielsenBent EjlertsenHenning T. Mouridsen Preclinical study 17 June 2010 Pages: 345 - 355
PALB2 analysis in BRCA2-like families M. A. AdankS. E. van MilH. Meijers-Heijboer Preclinical study 26 June 2010 Pages: 357 - 362
Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancer François BertucciNathalie BoriePatrice Viens Preclinical study 29 June 2010 Pages: 363 - 373
Dual targeting of EphA2 and ER restores tamoxifen sensitivity in ER/EphA2-positive breast cancer Yesim Gökmen-PolarRachel A. ToroniKathy D. Miller Preclinical study 03 July 2010 Pages: 375 - 384
The liver receptor homolog-1 regulates estrogen receptor expression in breast cancer cells Paul T. R. ThiruchelvamChun-Fui LaiSimak Ali Preclinical study 06 July 2010 Pages: 385 - 396
Three-dimensional collagen represses cyclin E1 via β1 integrin in invasive breast cancer cells Yuehan WuXun GuoRebecca S. Hartley Preclinical study 04 July 2010 Pages: 397 - 406
Clinicopathologic and molecular significance of phospho-Akt expression in early invasive breast cancer Mohammed A. AleskandaranyEmad A. RakhaAndrew R. Green Preclinical study 09 July 2010 Pages: 407 - 416
Estrogen receptor beta decreases survival of p53-defective cancer cells after DNA damage by impairing G2/M checkpoint signaling Christoforos G. ThomasAnders StromJan-Ake Gustafsson Preclinical study 10 July 2010 Pages: 417 - 427
Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01–04) for women with stage II/III breast cancer R. ColemanE. WoodwardH. Thorpe Clinical Trial 11 March 2011 Pages: 429 - 438
Immediate reconstruction with implants in women with invasive breast cancer does not affect oncological safety in a matched cohort study C. EriksenJ. FrisellK. Sandelin Clinical trial 16 March 2011 Pages: 439 - 446
Strength training stops bone loss and builds muscle in postmenopausal breast cancer survivors: a randomized, controlled trial Kerri M. Winters-StoneJessica DobekAnna Schwartz Clinical trial 19 March 2011 Pages: 447 - 456
Erratum to: Strength training stops bone loss and builds muscle in postmenopausal breast cancer survivors: a randomized, controlled trial Kerri M. Winters-StoneJessica DobekAnna Schwartz Erratum 19 April 2011 Pages: 457 - 457
Accuracy of unidimensional and volumetric ultrasound measurements in predicting good pathological response to neoadjuvant chemotherapy in breast cancer patients I. GounarisE. ProvenzanoR. Sinnatamby Clinical Trial 25 March 2011 Pages: 459 - 469
Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry Melinda L. TelliEllen T. ChangScarlett L. Gomez Epidemiology 19 October 2010 Pages: 471 - 478
Discriminatory accuracy and potential clinical utility of genomic profiling for breast cancer risk in BRCA-negative women E. ComenL. BalistreriM. Robson Epidemiology 19 October 2010 Pages: 479 - 487
Germline mutations in BRCA1 and BRCA2 genes in ethnically diverse high risk families in Israel Yael LaitmanRoni Tsipora BorstheinEitan Friedman Epidemiology 20 October 2010 Pages: 489 - 495
Periodontal disease may associate with breast cancer Birgitta SöderMaha YakobPer-Östen Söder Epidemiology 20 October 2010 Pages: 497 - 502
Genetic variation in the androgen estrogen conversion pathway in relation to breast cancer prognosticators Hatef DarabiKamila CzeneKeith Humphreys Epidemiology 20 October 2010 Pages: 503 - 509
Chemotherapy characteristics are important predictors of primary prophylactic CSF administration in older patients with breast cancer Suja S. RajanGary H. LymanSally C. Stearns Epidemiology 26 October 2010 Pages: 511 - 520
Out of pocket cost comparison between Caucasian and minority breast cancer survivors in the Breast Cancer Education Intervention (BCEI) Maria PisuAndres AzueroPatrick McNees Epidemiology 26 October 2010 Pages: 521 - 529
The role of polymorphisms in circadian pathway genes in breast tumorigenesis Hongji DaiLina ZhangKexin Chen Epidemiology 27 October 2010 Pages: 531 - 540
Improvement in self-reported physical health predicts longer survival among women with a history of breast cancer Ruth E. PattersonNazmus SaquibJohn P. Pierce Epidemiology 03 November 2010 Pages: 541 - 547
Genetic variants within miR-126 and miR-335 are not associated with breast cancer risk Rongxi YangMichelle DickBarbara Burwinkel Epidemiology 03 November 2010 Pages: 549 - 554
Circulating levels of inflammatory markers and mammographic density among postmenopausal women Katherine W. ReevesJoel L. WeissfeldBrenda Diergaarde Epidemiology 11 November 2010 Pages: 555 - 563
Further studies based on better design are needed to explore the association of NPAS2 gene polymorphisms with breast cancer Fang WangYan-Feng Zou Letter to the Editor 14 January 2011 Pages: 565 - 568
VEGF 936C>T polymorphism and breast cancer risk: evidence needed further clarification Liu LiuFu-Zhou HuaPei-Qian Zhu Letter to the Editor 20 January 2011 Pages: 569 - 571
Soy consumption and breast cancer risk: four recent meta-analyses Chun ZhangJian-Ping LiPing Zhou Letter to the Editor 26 January 2011 Pages: 573 - 576
Inspection of a deviation from Hardy–Weinberg equilibrium in familial breast cancer cases from a case–control study in a meta-analysis Ke-Da YuZhi-Ming Shao Letter to the Editor 29 January 2011 Pages: 577 - 579
Green tea consumption and breast cancer risk: three recent meta-analyses Ping ZhouJian-Ping LiChun Zhang Letter to the Editor 29 January 2011 Pages: 581 - 583
Anthracyclines and trastuzumab; getting to the heart of the matter: when getting to the heart is the matter Patrick G. MorrisClifford A. Hudis Invited Commentary 13 September 2008 Pages: 585 - 586
Estrogen receptor: is it predictive for response to cytotoxic as well as hormonal therapy? Kathleen I. Pritchard Invited Commentary 04 February 2009 Pages: 587 - 588
Can strategies targeting cleaved MUC1 overcome resistance to trastuzumab? Kazuhiro ArakiMark Pegram Invited commentary 16 October 2009 Pages: 589 - 590
